Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Grupo SIMEC
SIM
$4.37B
| $382K | ﹤0.01% |
14,058
-158
| -1% | -$4.27K |
|
3077
J.W. Mays
MAYS
$78.7M
| $379K | ﹤0.01% |
8,620
| – | – |
|
3078
BlackSky Technology
BKSY
$898M
| $378K | ﹤0.01% |
+35,072
| New | +$300K |
|
|
SLRN
3079
DELISTED
ACELYRIN
SLRN
| $371K | ﹤0.01% |
+118,241
| New | +$572K |
|
3080
Zedge
ZDGE
$38.4M
| $365K | ﹤0.01% |
135,624
-4
| -0% | -$12 |
|
|
ACB
3081
Aurora Cannabis
ACB
$168M
| $361K | ﹤0.01% |
84,921
+5,800
| +7% | +$28.5K |
|
3082
Gevo
GEVO
$363M
| $358K | ﹤0.01% |
171,498
+91
| +0.1% | +$172 |
|
3083
NCS Multistage Holdings
NCSM
$117M
| $355K | ﹤0.01% |
13,679
+1,689
| +14% | +$37.3K |
|
3084
AC Immune
ACIU
$236M
| $355K | ﹤0.01% |
131,410
+74,358
| +130% | +$232K |
|
|
JOYY
3085
JOYY Inc
JOYY
$3.77B
| $351K | ﹤0.01% |
8,395
| – | – |
|
3086
Praxis Precision Medicines
PRAX
$8.25B
| $350K | ﹤0.01% |
4,544
-545
| -11% | -$39.4K |
|
|
IROQ
3087
DELISTED
IF Bancorp
IROQ
| $349K | ﹤0.01% |
15,173
+1,320
| +10% | +$28.6K |
|
3088
Melco Resorts & Entertainment
MLCO
$2.19B
| $348K | ﹤0.01% |
60,159
| – | – |
|
|
VTYX
3089
DELISTED
Ventyx Biosciences
VTYX
| $347K | ﹤0.01% |
+158,288
| New | +$359K |
|
3090
Brookfield Asset Management
BAM
$76.7B
| $342K | ﹤0.01% |
6,318
-4,011
| -39% | -$217K |
|
3091
Biohaven
BHVN
$2.07B
| $342K | ﹤0.01% |
9,147
-10
| -0.1% | -$467 |
|
3092
ImmuCell
ICCC
$102M
| $341K | ﹤0.01% |
66,306
-6,376
| -9% | -$25.4K |
|
3093
Fossil Group
FOSL
$262M
| $339K | ﹤0.01% |
203,050
+8,286
| +4% | +$12.1K |
|
3094
CKX Lands
CKX
$22.2M
| $339K | ﹤0.01% |
26,903
| – | – |
|
|
FGNX
3095
FG Nexus Inc
FGNX
$39.5M
| $338K | ﹤0.01% |
2,905
-647
| -18% | -$81.7K |
|
3096
Reading International Class A
RDI
$33.2M
| $337K | ﹤0.01% |
255,291
-54,315
| -18% | -$80.3K |
|
3097
Pathfinder Bancorp
PBHC
$100M
| $335K | ﹤0.01% |
19,640
+1,032
| +6% | +$17.8K |
|
3098
Ultragenyx Pharmaceutical
RARE
$2.56B
| $326K | ﹤0.01% |
7,747
-1
| -0% | -$50 |
|
3099
Sera Prognostics
SERA
$79.5M
| $324K | ﹤0.01% |
39,705
+99
| +0.2% | +$728 |
|
3100
First National Corp
FXNC
$274M
| $323K | ﹤0.01% |
14,041
+2,398
| +21% | +$53.6K |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.